Nrd Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 484.63%
- Profit Growth 499.02%
- Ebitda 97.87%
- Net Worth 19.70%
- Total Assets 84.72%
About Nrd Healthcare
Nrd Healthcare Private Limited (NHPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 May 2020 (Four years and nine months 20 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Sukumaran Sumod, Nanmail Dathathrayakamath, and Indira Narayana serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85190KL2020PTC062032
- Company No.
062032
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Nrd Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukumaran Sumod  | Director | 05-May-2020 | Current |
| Nanmail Dathathrayakamath | Director | 05-May-2020 | Current |
| Indira Narayana | Director | 05-May-2020 | Current |
Financial Performance of Nrd Healthcare.
Nrd Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 484.63% increase. The company also saw a substantial improvement in profitability, with a 499.02% increase in profit. The company's net worth Soared by an impressive increase of 19.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nrd Healthcare?
Unlock access to Nrd Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Tamlur Builders Private LimitedSukumaran Sumod is a mutual person
- Sainbaxy Labs Private Limited
Sukumaran Sumod is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nrd Healthcare?
Nrd Healthcare has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nrd Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nrd Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.